Literature DB >> 11036184

Allosteric modulation in spontaneously active mutant gamma-aminobutyric acid(A) receptors [corrected].

G S Findlay1, S Ueno, N L Harrison, R A Harris.   

Abstract

Tryptophan substitutions were made in the second transmembrane domain of the gamma-aminobutyric acid(A) (GABA(A)) receptor alpha and beta subunits and the resulting mutant receptors, containing alpha(2)(S270W) and/or beta(1)(S265W), were expressed in Xenopus oocytes. Mutation of either or both subunits resulted in receptors that exhibited enhanced sensitivity to agonist and were spontaneously active in the absence of GABA. The spontaneous activity was blocked by picrotoxin or bicuculline. The enhancement of GABA-induced currents by pentobarbital, by the neurosteroid 5alpha-pregnan-3alpha-ol-20-one, and by the benzodiazepine flunitrazepam was dramatically reduced in the mutant receptors. These results are consistent with the idea that a mutation that promotes gating behavior in a ligand-gated ion channel will also show reduced effects of all positive allosteric modulators in a generalized manner, even when these modulators act at distinct sites on the receptor.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11036184     DOI: 10.1016/s0304-3940(00)01503-2

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  3 in total

Review 1.  GABA(A) receptors and alcohol.

Authors:  Ingrid A Lobo; R Adron Harris
Journal:  Pharmacol Biochem Behav       Date:  2008-03-14       Impact factor: 3.533

2.  Evidence for the formation of functionally distinct alphabetagammaepsilon GABA(A) receptors.

Authors:  P A Davies; E F Kirkness; T G Hales
Journal:  J Physiol       Date:  2001-11-15       Impact factor: 5.182

3.  Benzodiazepine modulation of partial agonist efficacy and spontaneously active GABA(A) receptors supports an allosteric model of modulation.

Authors:  Scott S Downing; Yan T Lee; David H Farb; Terrell T Gibbs
Journal:  Br J Pharmacol       Date:  2005-08       Impact factor: 8.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.